Dr. Christopher Barde, MD

Gastroenterology Dayton, OH Male
NPI: 1215918263
Total Payments
$5,350
2023 Payments
$262.43
Companies
29
Transactions
287
Medicare Patients
728
Medicare Billing
$325,006

Payment Breakdown by Category

Food & Beverage$5,350 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $5,350 287 100.0%

Top Paying Companies

Company Total Records Latest Year
AbbVie Inc. $1,573 82 $0 (2023)
PFIZER INC. $912.75 67 $0 (2022)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $744.00 52 $0 (2022)
QOL Medical, LLC $265.89 5 $0 (2022)
Synergy Pharmaceuticals Inc $178.56 4 $0 (2018)
Evoke Pharma, Inc. $166.28 4 $0 (2023)
Daiichi Sankyo Inc. $152.71 8 $0 (2022)
Ethicon US, LLC $139.51 3 $0 (2021)
Takeda Pharmaceuticals U.S.A., Inc. $126.01 11 $0 (2022)
Janssen Scientific Affairs, LLC $124.99 1 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2023 $262.43 7 Evoke Pharma, Inc. ($124.98)
2022 $1,122 76 ABBVIE INC. ($350.43)
2021 $1,480 96 AbbVie Inc. ($488.10)
2020 $545.94 31 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($221.06)
2019 $1,206 60 AbbVie, Inc. ($452.65)
2018 $500.58 14 Synergy Pharmaceuticals Inc ($178.56)
2017 $233.29 3 Covidien LP ($118.73)

All Payment Transactions

287 individual payment records from CMS Open Payments — Page 1 of 12

Date Company Product Nature Form Amount Type
10/03/2023 Braintree Laboratories, Inc. SUFLAVE (Drug) Food and Beverage In-kind items and services $20.04 General
Category: GI COLON PREP
02/13/2023 INTERCEPT PHARMACEUTICALS, INC. OCALIVA (Drug) Food and Beverage In-kind items and services $13.63 General
Category: Hepatology / Gastroenterology
02/11/2023 Gilead Sciences, Inc. — Food and Beverage In-kind items and services $20.64 General
02/09/2023 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $27.98 General
Category: Immunology
01/30/2023 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $26.19 General
Category: Immunology
01/26/2023 Evoke Pharma, Inc. GIMOTI (Drug) Food and Beverage In-kind items and services $124.98 General
Category: Gastroenterology
01/12/2023 AbbVie Inc. RINVOQ (Biological), HUMIRA Food and Beverage In-kind items and services $28.97 General
Category: IMMUNOLOGY
12/07/2022 ABBVIE INC. RINVOQ (Biological), HUMIRA Food and Beverage In-kind items and services $15.04 General
Category: IMMUNOLOGY
12/02/2022 PFIZER INC. XELJANZ (Drug) Food and Beverage In-kind items and services $3.48 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
11/18/2022 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $7.43 General
Category: IMMUNOLOGY
11/15/2022 ABBVIE INC. RINVOQ (Biological), HUMIRA Food and Beverage In-kind items and services $15.10 General
Category: IMMUNOLOGY
11/05/2022 PFIZER INC. XELJANZ (Drug) Food and Beverage In-kind items and services $17.50 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
10/28/2022 PFIZER INC. XELJANZ (Drug) Food and Beverage In-kind items and services $19.54 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
10/13/2022 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $12.23 General
Category: IMMUNOLOGY
10/13/2022 PFIZER INC. XELJANZ (Drug) Food and Beverage In-kind items and services $2.52 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
10/11/2022 QOL Medical, LLC SUCRAID (Drug) Food and Beverage Cash or cash equivalent $124.52 General
Category: THERAPY FOR CSID
09/16/2022 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $13.12 General
Category: IMMUNOLOGY
09/06/2022 PFIZER INC. XELJANZ (Drug) Food and Beverage In-kind items and services $15.93 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
08/25/2022 PFIZER INC. XELJANZ (Drug) Food and Beverage In-kind items and services $13.12 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
08/25/2022 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $13.09 General
Category: IMMUNOLOGY
08/23/2022 PFIZER INC. XELJANZ (Drug) Food and Beverage In-kind items and services $1.98 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
08/11/2022 QOL Medical, LLC SUCRAID (Drug) Food and Beverage Cash or cash equivalent $21.05 General
Category: THERAPY FOR CSID
08/09/2022 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $20.24 General
Category: IMMUNOLOGY
08/09/2022 PFIZER INC. XELJANZ (Drug) Food and Beverage In-kind items and services $1.92 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
08/02/2022 PFIZER INC. XELJANZ (Drug) Food and Beverage In-kind items and services $20.15 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
123…12»

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 1 34 35 $7,385 $1,616
2022 5 258 9,082 $339,584 $178,512
2021 6 248 5,759 $242,866 $120,207
2020 4 188 315 $73,219 $24,671
Total Patients
728
Total Services
15,191
Medicare Billing
$325,006
Procedure Codes
16

All Medicare Procedures & Services

16 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 34 35 $7,385 $1,616 21.9%
J3380 Injection, vedolizumab, 1 mg Office 2022 17 8,703 $252,000 $146,426 58.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 155 274 $58,386 $24,577 42.1%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 31 31 $10,974 $3,443 31.4%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 33 34 $4,624 $2,141 46.3%
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less Office 2022 22 40 $13,600 $1,926 14.2%
J3380 Injection, vedolizumab, 1 mg Office 2021 12 5,404 $162,000 $89,185 55.1%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 122 219 $46,352 $20,715 44.7%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 59 59 $20,886 $7,074 33.9%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 25 26 $3,536 $1,730 48.9%
96365 Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Office 2021 16 27 $9,180 $1,490 16.2%
J7050 Infusion, normal saline solution, 250 cc Office 2021 14 24 $912.00 $13.48 1.5%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 107 220 $46,849 $16,607 35.4%
99204 New patient office or other outpatient visit, typically 45 minutes Office 2020 51 51 $18,054 $5,669 31.4%
96413 Infusion of chemotherapy into a vein up to 1 hour Office 2020 15 22 $7,480 $2,351 31.4%
J7030 Infusion, normal saline solution , 1000 cc Office 2020 15 22 $836.00 $44.89 5.4%

About Dr. Christopher Barde, MD

Dr. Christopher Barde, MD is a Gastroenterology healthcare provider based in Dayton, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/08/2005. The National Provider Identifier (NPI) number assigned to this provider is 1215918263.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Barde, MD has received a total of $5,350 in payments from pharmaceutical and medical device companies, with $262.43 received in 2023. These payments were reported across 287 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($5,350).

As a Medicare-enrolled provider, Barde has provided services to 728 Medicare beneficiaries, totaling 15,191 services with total Medicare billing of $325,006. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.

Practice Information

  • Specialty Gastroenterology
  • Location Dayton, OH
  • Active Since 11/08/2005
  • Last Updated 12/02/2019
  • Taxonomy Code 207RG0100X
  • Entity Type Individual
  • NPI Number 1215918263

Products in Payments

  • XELJANZ (Drug) $817.56
  • XIFAXAN (Drug) $629.39
  • HUMIRA (Biological) $376.81
  • Humira (Biological) $341.91
  • SUCRAID (Drug) $265.89
  • CREON (Drug) $249.60
  • STELARA (Biological) $227.81
  • LINZESS (Drug) $182.65
  • Trulance (Drug) $178.56
  • GIMOTI (Drug) $166.28
  • INJECTAFER (Drug) $152.71
  • RINVOQ (Biological) $139.33
  • Barrx (Device) $118.73
  • ZEPOSIA (Drug) $98.10
  • MAVYRET (Drug) $83.62
  • Talicia (Drug) $77.69
  • Mavyret (Drug) $77.64
  • CLENPIQ (Drug) $75.65
  • TRULANCE (Drug) $72.29
  • LINX Reflux Management System (Device) $65.51

Explore

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Gastroenterology Doctors in Dayton

Ramesh Gandhi, Md, MD

Gastroenterology — Payments: $25,228

Gastroenterology $25,228

Jigna Thakore, Md, MD

Gastroenterology — Payments: $14,949

Gastroenterology $14,949

Vasundhara Appalaneni, Md, MD

Gastroenterology — Payments: $14,903

Gastroenterology $14,903

Rajkamal Jit, Md, MD

Gastroenterology — Payments: $14,506

Gastroenterology $14,506

Bikram Verma Ansil, Md, MD

Gastroenterology — Payments: $12,650

Gastroenterology $12,650

Teressa Patrick, Md, MD

Gastroenterology — Payments: $10,945

Gastroenterology $10,945